Squarepoint’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-15,463
Closed -$345K 3940
2021
Q1
$345K Sell
15,463
-26,517
-63% -$608K ﹤0.01% 2302
2020
Q4
$822K Buy
41,980
+13,604
+48% +$226K 0.01% 1461
2020
Q3
$398K Sell
28,376
-24,258
-46% -$350K 0.01% 1607
2020
Q2
$596K Buy
52,634
+34,119
+184% +$312K 0.01% 1215
2020
Q1
$116K Sell
18,515
-40,592
-69% -$655K ﹤0.01% 1613
2019
Q4
$1.2M Sell
59,107
-17,291
-23% -$324K 0.01% 1225
2019
Q3
$1.27M Buy
76,398
+53,349
+231% +$923K 0.01% 1069
2019
Q2
$379K Sell
23,049
-129,398
-85% -$2.5M ﹤0.01% 1822
2019
Q1
$2.68M Buy
152,447
+119,484
+362% +$2.54M 0.03% 655
2018
Q4
$818K Buy
+32,963
New +$1.1M 0.01% 1005
2018
Q2
Sell
-24,102
Closed -$956K 2161
2018
Q1
$956K Buy
24,102
+16,620
+222% +$645K 0.02% 824
2017
Q4
$273K Sell
7,482
-20,583
-73% -$781K ﹤0.01% 1582
2017
Q3
$1.15M Buy
+28,065
New +$1.09M 0.02% 680
2017
Q1
Sell
-16,530
Closed -$376K 2031
2016
Q4
$376K Buy
+16,530
New +$389K 0.02% 1001

Other funds holding TVTY

Squarepoint's TVTY Position: Q2 2021 in Review

Squarepoint sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2021, closing a stake of 15,463 shares — an estimated $345K sold.

Squarepoint first reported a position in TVTY in Q4 2016 and held it in 14 quarters. The position peaked at $2.68M in Q1 2019. 163 funds tracked by Wall St. Rank hold TVTY as of Q2 2021.

  • Squarepoint reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 15,463 Tivity Health, Inc. Common Stock shares in Q2 2021, an estimated $345K.
  • Squarepoint first reported a position in Tivity Health, Inc. Common Stock in Q4 2016 and held it in 14 quarters.
  • Squarepoint's Tivity Health, Inc. Common Stock position peaked at $2.68M in Q1 2019.
  • 163 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.